The World Influenza Congress Europe 2011 - Speaker list

Daniel Adams Executive Chairman at Protein Science

Dr. Baker is the inventor of the platform technology, founder of NanoBio and an internationally recognized expert in immunology and nanotechnology. Dr. Baker invented the NanoStat technology at the University of Michigan, where he is the Ruth Dow Doan Professor of...

Carlton Brown, BVSc MBA, is CEO & co-founder of Immune Targeting Systems. He is co-inventor of the DepoVaccine™ & Densigen™ T-cell vaccine platforms, innovated to permit the rational targeting of mutating viruses and cancer. Since co-founding ITS he has raised £14.5m...

Myung-Sam Cho is Chief Senior Advisor, R&D at Celltrion Ltd

Dennis Christensen, Pharmaceutical Scientist, graduated from Faculty of Pharmaceutical Sciences, University of Copenhagen in 2005, and obtained his PhD from the same institution in 2008. Since 2004 he has been working in Department of Infectious Disease Immunology at...

Graham has a postgraduate degree in Biophysics from Kings College London and an MBA. He has worked in the healthcare industry in a number of roles – as a project manager in R&D, in product management, sales & marketing, planning & strategy and business development. He...

Anthony Edward (Tony) Colegate B.Sc. Hon's (Applied Biology) M.I.Biol. C.Biol. is currently the Influenza Technical Affairs Manager at Novartis Vaccines, Liverpool. He has over 40 years experience in commercial vaccine production with Pfizer, Glaxo, Evans...

Anne S. De Groot earned her B.S. at Smith College, her M.D. at the Pritzker School of Medicine / University of Chicago, worked on field campaigns to vaccinate against measles in Zaire, then trained in Internal Medicine (New England Medical Center), earned a research...

Dr. Desaintes graduated as an Agronomist Engineer from the Catholic University of Leuven (Belgium) in 1984 and later as Doctor in Sciences from the Free University of Brussels (Belgium). He has performed research for more than 16 years in...

Debbie Drane has been with CSL in the R&D Division for over 25 years. During this time she has had a number of roles and has substantial experience in most areas of vaccine development. In particular she has worked on CSL’s proprietary ISCOMATRIX® adjuvant for many...

Dr Othmar G Engelhardt is a Principal Scientist in the Division of Virology of the National Institute for Biological Standards and Control, a centre of the Health Protection Agency, UK. He received a doctorate degree from the University of Natural Resources and Applied ...

Robert Friesen currently holds the position of Vice President of Preclinical and Clinical Research at Crucell. He joined Crucell on the 1st of August 2008 as Vice President of Antibody Discovery. He has been working in research and development of peptides, enzymes and...

Ed Geuns is Director Regulatory Affairs, Vaccines, at Abbott Biologicals B.V. in Weesp, the Netherlands. He was awarded a MSc degree in pharmacy by the University of Leiden and a PharmD degree by the University of Utrecht. From 1990 until 1997 he was (senior)...

Dr. Hinkula is Director of Immunology at Eurocine Vaccines AB and Professor of Molecular Virology at Linköping University. He has over 20 years of experience from the field of vaccines with focus on virology and mucosal immunology. Dr Hinkula's research has involved...

Otfried received his diploma in biology in 1984 and his Ph.D. in Virology in 1987 from the Justus-Liebig-University in Giessen, Germany. The topic of his thesis was the phosphorylation of the nucleoprotein of influenza viruses and its role in host cell tropism. He...

Dr. Yotam Levin is the Chief Executive Officer of NanoPass Technologies Ltd. for more than nine years. He is in charge of the Company's strategy, business development, and all clinical activities. Under his supervision the Company successfully registered its product...

Melissa Malhame., MBA is the Sr. Director of Marketing and Product Management at Dynavax Technologies. Ms. Malhame holds a MBA from Cornell University's Johnson Graduate School of Management in marketing and general management. Melissa has worked during the past...

Dr John McCauley has been Director of the WHO Collaborating Centre for Reference and Research on Influeza in the Division of Virology, MRC National Institute fro Medical Research in London UK. He is also a programme leader in Virology in the Institute. John McCauley...

Alain Moren is Director, Epidemiology Department at EpiConcept.

Dr. Thomas Muster is CEO/CSO and co-founder of AVIR Green Hills Biotechnology. He obtained his PhD in Biotechnology from the University of Natural Resources and Applied Life Sciences in Vienna and is Associate Professor for Virology. Prior to AVIR Green Hills...

Dr Pieter Neels is a native of Belgium where he trained as an MD (University of Antwerp, 1985) and was boarded as a general practitioner. Between 1986 and 1994 he was an active general practitioner in Antwerp. In 1994, his interest for medical research led him to work...

Nikiforova Alexandra Nikolaevna is Chief expert of the Department of Clinical Research of Administration of Clinical Research and Registration of medicines at FSUC «SIC «Microgen» MOHSD RF, Russia. She received immunological, microbiological and biochemistry degree at...

John Oxford is Professor of Virology at St Bartholomew’s and the Royal London Hospital, Queen Mary’s School of Medicine and Dentistry. He has co-authored two standard texts: ‘Influenza, the Viruses and the Disease’ with Sir Charles Stuart-Harris and G.C. Schild;...

Dr. Palache (1952) is currently Global Scientific and Public Affairs Director, Influenza Vaccines, Abbott Biologicals BV, and member of the IFPMA Influenza Vaccine Supply International Task Force. Dr. Palache received his MSc degree in Biochemistry at the University of ...

Charles is the inventor of the Glide technology and founder of Glide Pharma. He holds an engineering degree and PhD from Cambridge University. Charles spent six years undertaking research within the Transplant Unit at Papworth Hospital, a specialist cardiothoracic...

Mr. Radspinner is co-founder, President and Chief Executive Officer of FluGen Inc., a Madison, Wisconsin influenza vaccines company. After completing his MBA at Northwestern’s Kellogg Graduate School of Management he spent over 15 years in management roles...

Biography: Nigel Silman is the Strategic Coordinator for Research & Development at the Health Protection Agencys’ Centre for Emergency Preparedness & Response at Porton Down in the UK. He was educated at the Universities of Plymouth and Leicester. He has a background...

Ernst Soethout is coordinator innovation management at RIVM, the Netherlands, responsible for IP and business development. He graduated as doctor in Veterinary Medicine at Utrecht University in 1995 and was awarded a PhD in immunology from Utrecht University in...

Dr. Klaus Stohr is Vice President and Global Head of the Influenza Strategy Liaison for Novartis Vaccines in Boston, USA, where he leads adn coordinates cross-functional pandemic and prepandemic influenza vaccine activities, as well as driving influenza-based...

Dr. De-chu C. Tang is the Scientific Founder, Vice President of Research, and Chief Technical Officer at Vaxin Inc. He obtained his PhD in Microbiology from Indiana University in 1989. He carried out his postdoctoral work at Baylor College of Medicine, Duke...

Timo Vesikari is Professor of Virology and Paediatrics at University of Tampere

Helmut Walerius is a member of the "Health Threats Unit" of the Directorate General for Health and Consumers at the European Commission. He began his professional career with social security in Germany. After he had moved to the European Commission he held there...